Please login to the form below

Not currently logged in
Email:
Password:

beta thalassaemia

This page shows the latest beta thalassaemia news and features for those working in and with pharma, biotech and healthcare.

Bluebird bio launches beta thalassaemia gene therapy Zynteglo in Germany

Bluebird bio launches beta thalassaemia gene therapy Zynteglo in Germany

The one-off gene therapy was approved by the European Medicines Agency (EMA) last June, for patients 12 years and older with transfusion-dependent beta thalassaemia (TDT) who have no matching ... Zynteglo (autologous CD34+ cells encoding β

Latest news

More from news
Approximately 4 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...

Infographics